A 20-mer phosphorothioate oligonucleotide (AS1) was designed to hybridize to the message for the rat kidney sodium phosphate cotransporter NaPi-2 close to the translation initiation site. Single intravenous doses of this oligonucleotide were given to rats maintained on a low phosphorus diet to increase NaPi-2 expression. At 3 days after oligonucleotide infusion, rats receiving 2.5 micromol of AS1 exhibited a reduction in renal NaPi-2 to cyclophilin mRNA ratio by 40% +/-17%, and rats receiving 7.5 micromol of AS1 exhibited a reduction in NaPi-2 to cyclophilin mRNA ratio by 46% +/-21%. Reversed-sequence AS1 was without effect. The higher dose of 7.5 micromol of AS1 also reduced the rate of phosphate uptake into renal brush border membrane vesicles and the expression of NaPi-2 protein detected by Western blotting in these vesicles. Reversed sequence AS1 was again without effect on these parameters. These results suggest that systemically infused oligonucleotides can exert antisense effects in the renal proximal tubule. 
Antisense oligonucleotides offer a potential means to block expression of individual genes (1) (2) (3) (4) . The antisense effect of unmodified oligodeoxynucleotides is limited because they are rapidly degraded. Several structural modifications have therefore been employed to retard oligonucleotide degradation and thereby increase antisense activity. The modification most often employed has been the replacement of one oxygen of each internucleotide linkage with sulfur, which yields a phosphorothioate oligonucleotide (2) (3) (4) . Phosphorothioate oligonucleotides have frequently been shown to exert antisense activity in cultured cells but have less often been shown to exert antisense effects in vivo. Antisense activity may be more difficult to achieve in vivo in part because of limited oligonucleotide uptake by target tissues in living animals. Pharmacodynamic studies suggest, however, that the kidney proximal tubule could be a particularly suitable target tissue for phosphorothioate oligonucleotide antisense treatment in vivo. These studies have shown that a large portion of systemically infused phosphorothioate oligonucleotides, which are cleared rapidly from the circulation, are taken up by the kidney (5-7). Within the kidney, phosphorothioate oligonucleotides remain intact for several days and are localized predominantly in the proximal tubule (6, 7) . The current study was designed to determine whether phosphorothioate oligonucleotides cleared from the circulation by the kidney could exert antisense effects in proximal tubule cells. The recently identified rat proximal tubule sodium phosphate cotransporter, NaPi-2, was selected as a target for antisense treatment (8, 9) . Results showed suppression of the NaPi-2 message in kidney cortex, along with reduction of NaPi-2 protein and sodium phosphate cotransport in brush border membrane vesicles from rats that received a phosphorothioate oligonucleotide designed to hybridize with NaPi-2 mRNA.
MATERIALS AND METHODS
Oligonucleotides. Experiments were conducted with 18-and 20-mer phosphorothioate oligonucleotides. Three oligonucleotides, denoted AS1, AS2, and AS3, were designed to hybridize with mRNA for NaPi-2 (8) . ASI had the sequence 5'-TCC CCC CAA TCT CTC GCT GT-3' corresponding to positions 64-83 of the NaPi-2 cDNA, AS2 had the sequence 5'-CTC GCT GTA GGA CAT CAT-3' corresponding to positions 54-71 of the cDNA, and AS3 had the sequence 5'-GCA CCC ACA ATG AGT CCT-3' corresponding to positions 31-48 of the cDNA. Target sequences were in each case close to the presumed translation initiation site (positions 54-59 
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(Ultrascan Laser; LKB) or by Phosphorlmager (model 445 SI; Molecular Dynamics).
Western Analysis. Brush border membrane vesicles were prepared from kidney cortex using the MgCl2 precipitation method (11) . Samples of these vesicles were subjected to Western analysis. SDS/PAGE was performed as described by Laemmli (12) 
RESULTS
The effects of systemic infusion of oligonucleotides on renal expression of the message for NaPi-2 are depicted in Figs. 1 and 2. Experiments were performed first with 2.5-,umol doses of oligonucleotides. Densitometric analysis showed that at this dose, oligonucleotide AS1 reduced the NaPi-2 mRNA to cyclophilin mRNA ratio by an average of 40% ± 17%. This overall result was obtained in three separate experiments in which the NaPi-2 to cyclophilin mRNA ratio was reduced by 46% ± 10%, 42% ± 19%, and 29% ± 25%, respectively. In contrast, rAS1 and a scrambled sequence of AS1 did not affect renal NaPi-2 mRNA levels. NaPi-2 mRNA levels were likewise not significantly reduced by 2.5 ,tmol of the antisense oligonucleotides AS2 and AS3 (data not shown). The NaPi-2 mRNA to cyclophilin mRNA ratio was, however, lower in a group of rats maintained on normal chow than in control rats maintained on the low phosphorus diet, as has been described (16) . Administration of an increased dose of 7.5 ,tmol of AS1 reduced the NaPi-2 to cyclophilin mRNA ratio by 46% ± 21%, whereas infusion of an equal dose of rAS1 had no effect.
Systemic infusion of oligonucleotides had no effect on body weight, which remained stable (preinfusion, 289 ± 22 g; postinfusion, 289 ± 19 g) between oligonucleotide administration and sacrifice and was not different in oligonucleotideand saline-infused rats. . NaPi-2 to cyclophilin message ratios in the kidneys of rats after oligonucleotide treatment, expressed as a percent of the control ratio observed in rats receiving saline. A 2.5-,umol dose ofAS1 reduced the NaPi-2 to cyclophilin mRNA ratio by 41% ± 17% (mean of three separate experiments in which three, six, and five rats received AS1 and an equal number of rats received saline). Similar doses of rAS1 and scrambled ASl (sAS1) had no effect (separate experiments in which five rats received oligonucleotides and five rats received saline). A 7.5-j,mol dose of AS1 also reduced the NaPi-2 to cyclophilin mRNA ratio, whereas rAS1 in this dose again had no effect (separate experiments in which five rats received oligonucleotides and five rats received saline). As compared with rats maintained on a low phosphorus diet, the NaPi-2 to cyclophilin mRNA ratio was also reduced in rats maintained on normal chow (NC), which received no oligonucleotide [n = four NC rats versus six control rats on the low phosphorus diet; *, P < 0.05 vs. simultaneous control (assigned 100%)].
Western analysis of brush border membrane proteins obtained from rats receiving 7.5 ,umol of oligonucleotides is illustrated in Fig. 3 . In two separate experiments, densitometry showed that AS1 reduced staining of the 85-kDa protein that is recognized by antibody raised against NaPi-2 peptide by 60% ± 19% and by 84% ± 20% (both P < 0.05; overall mean reduction 72% ± 20%). By contrast, a 7.5-,tmol dose of AS1 had no effect on the amount of alkaline phosphatase or keratin 8 in brush border membranes (Fig. 3) , and an equal dose of rAS1 had no effect on the 85-kDa protein recognized by antibody against NaPi-2 peptide (data not shown). Statistically significant reduction in the 85-kDa protein was not observed in vesicles from rats that received 2.5 ,umol of AS1 (57% ± 30% of control, P > 0.05).
The time course of phosphate uptake by brush border membrane vesicles from rats that received 7.5 ,umol of oligonucleotides is depicted in Fig. 4 NaPi-2 message expression, whereas rAS1 had no effect. Western analysis of brush border membrane proteins in rats receiving 7.5 ,umol of oligonucleotides. In comparison with saline infusion in simultaneously prepared control rats (C), AS1 reduced the expression of 85-kDa protein detected by a polyclonal antibody raised against a peptide sequence of NaPi-2 (9), but it had no effect on proteins detected by antisera against alkaline phosphatase and keratin 8. brush border membrane vesicles from rats that received 2.5 ,umol of AS1 (data not shown).
DISCUSSION
Effective use of antisense oligonucleotides in vivo has been limited in part because it is difficult to achieve adequate cellular uptake of oligonucleotides in target tissues. To date, the most extensive studies of antisense therapy in vivo have been performed in the rat carotid restenosis model (4, 17, 18 ). In this model, genes promoting vascular growth have been suppressed by local application of antisense oligonucleotides incorporated into gels or into liposomes containing viral proteins to increase tissue uptake. Following parenteral administration without special preparation to facilitate tissue uptake, phosphorothioate oligonucleotides have been shown to block increased expression of genes associated with malignant cell proliferation and to retard tumor growth in mice (4, 19) . A single study has demonstrated suppression of a normal, constituitively expressed host gene following parenteral antisense treatment (20) . This study demonstrated reduction in hepatic expression of PKC-a in mice receiving intraperitoneal injections of a 20-mer phosphorothioate oligonucleotide.
The present study sought to show whether a systemically infused phosphorothioate oligonucleotide could exert antisense effects in the renal proximal tubule. Pharmacodynamic studies have shown that phosphorothioate oligonucleotides are taken up by the kidney in large quantity following systemic infusion and remain intact in kidney cells over several days (5) (6) (7) . Autoradiographic studies by the authors have shown further that phosphorothioate oligonucleotides taken up by the kidney are localized predominantly in the proximal tubule (7). Other recent studies suggest that proximal tubule cells possess a specific transport mechanism for uptake of oligonucleotides from the tubule lumen (21) . Together, these studies suggest that the renal proximal tubule might be a particularly suitable target for antisense treatment. Studies were therefore performed with antisense targeted against the sodium phosphate cotransporter NaPi-2. NaPi-2 is known to be localized in the proximal tubule of the rat and appears to be responsible for a major portion of tubular phosphate reabsorption in this species (8, 9, 22) Studies were performed in rats maintained on a low phosphate diet, as this maneuver has been shown to increase NaPi-2 expression and sodium phosphate cotransport in the rat proximal tubule (15, 23) .
Results showed suppression of NaPi-2 message expression by ASI, which was one of three phosphorothioate oligonucleotides designed to hybridize with NaPi-2 mRNA. The finding that gene expression was suppressed by only one of several potential antisense molecules is in accord with results of previous studies (20) . An activity. The finding that AS1 reduced phosphate uptake but not sulfate uptake into brush border membrane vesicle provided additional evidence that AS1 caused specific suppression of NaPi-2 activity and did not cause generalized suppression of proximal tubule function.
The mechanism by which systemically infused phosphorothioate oligonucleotides enter proximal tubule cells remains to be identified. Peptides molecules in the size range of oligonucleotides, however, are known to be filtered by the glomerulus, reabsorbed in the proximal tubule by receptor-mediated endocytosis, and then degraded in lysosomes (25) . Oligonucleotides confined within lysosomes would presumably exert no antisense effect. Phosphorothioate oligonucleotides are resistant to enzymatic degradation, however, and studies in cultured cells have suggested that they may escape from the endocytic-lysosomal pathway (26, 27) . In addition, the endocytic pathway may not be the only means of phosphorothioate oligonucleotide entry into cells (26, 28, 29 
